Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs SpaceX — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B), while SpaceX trades at $162.57 (market cap $2.18T). The key difference: SpaceX is far larger — about 360.9× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and SpaceX for 41 Days on average.
| IOVA | SPCX | |
|---|---|---|
Market Cap | $6.04B | $2.18T |
Volume | 14,805,993 | 68,508,567 |
Sector | Health | Industrials |
52-Week High | $14.82 | $202.09 |
52-Week Low | $1.81 | $108.27 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $5.97B | $2.12T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
